Nutritional support for malnourished patients with cancer

Current Opinion in Supportive and Palliative Care

Volumn 5, Issue 1, 2011, Pages 29-36

  Baldwin, Christine ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cachexia; Food; Malnutrition; Nutritional support; Oral nutritional supplements; Weight loss

Indexed keywords

ANTIINFLAMMATORY AGENT; APPETITE STIMULANT; CYTOKINE;

ARTICLE; CACHEXIA; DIET SUPPLEMENTATION; DIET THERAPY; DRUG ANTAGONISM; HUMAN; MALNUTRITION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; WEIGHT REDUCTION;

ANTI-INFLAMMATORY AGENTS; APPETITE STIMULANTS; CACHEXIA; COMBINED MODALITY THERAPY; CYTOKINES; DIETARY SUPPLEMENTS; HUMANS; MALNUTRITION; NEOPLASMS; NUTRITION ASSESSMENT; NUTRITIONAL SUPPORT; WEIGHT LOSS;

EID: 79954474358     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e328343a05d     Document Type: Article

References (46)

1. International Agency for Research on Cancer (IARC). GLOBOCAN 2008: Cancer incidence and Mortality Worldwide in 2008. http://globocan.iarc.fr/ [Accessed 5 October 2010].
2. Garcia M, Jemal A, Ward EM, et al. Global cancer: facts and figures in 2007; 2007.
3. Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998; 34:503-509. (Pubitemid 28179346)
4. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69:491-497. (Pubitemid 10018703)
5. Ross PJ, Ashley S, Norton A, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004; 90:1905-1911. (Pubitemid 38746329)
6. August DA, Huhmann MB. ASPEN Clinical Guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 2009; 33:472-500. Guidelines from the ASPEN on the use of nutritional support in the management of cancer patients.
7. Arends J, Bodoky G, Bozzetti F, et al. ESPEN Guidelines on Enteral Nutrition: nonsurgical oncology. Clin Nutr 2006; 25:245-259. (Pubitemid 43811685)
8. Bauer JD, Ash S, Davidson WL, et al. Evidence-based guidelines for the nutritional management of cancer cachexia and chronic kidney disease. Nutr Dietetics 2006; 63:S1-S45.
9. Elia M. Screening for malnutrition: a multidisciplinary responsibility. Development and use of the 'Malnutrition Universal Screening Tool' (MUST) for adults by the MAG, a standing committee of BAPEN; 2003. wwwbapenorguk.
10. Jensen GL, Mirtallo J, Compher C, et al. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting fromthe International Consensus GuidelineCommittee. Clin Nutr 2010; 29:151-153. An important article in that it proposes a new definition of malnutrition encompassing consideration of the underlying disease effects in the etiology and the importance of considering disease management in tandem with nutritional support. It links well with the proposed new definitions of cachexia.
11. Bozzetti F, Mariani L. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr 2009; 33:361-367. Article includes a review of preceding definitions of cachexia with some historical context and then describes the components of a proposed new definition of cachexia.
12. Laviano A, Meguid MM, Inui A, et al. Therapy insight. Cancer anorexiacachexia syndrome: when all you can eat is yourself. Nat Clin Pract Oncol 2005; 2:158-165. (Pubitemid 40823167)
13. Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83:1345-1350. (Pubitemid 44713065)
14. Argiles JM, Anker SD, Evans WJ, et al. Consensus on cachexia definitions. J Am Med Dir Assoc 2010; 11:229-230.
15. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and precachexia: joint document elaborated by Special Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and 'nutrition in geriatrics'. Clin Nutr 2010; 29:154-159. Outlines the proposed new definitions for cachexia and precachexia.
16. Blum D, Omlin A, Fearon K, et al. Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer 2010; 18:273-279. An excellent review of the diagnosis and treatment of cancer cachexia.
17. Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr 2008; 27:793-799.
18. Tan BH, Fearon KC. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care 2008; 11:400-407.
19. Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007; 34:94-104. (Pubitemid 46970881)
20. Strain AJ. Cancer cachexia in man: a review. Invest Cell Pathol 1979; 2:181-193. (Pubitemid 10227905)
21. Baldwin C, McGough C, Spiro A, et al. Nutritional and clinical characteristics of patients with gastrointestinal tract cancers at presentation. Proc Nutr Soc 2009; 68:E18.
22. Ramos Chaves M, Boleo-Tome C, Monteiro-Grillo I, et al. The diversity of nutritional status in cancer: new insights. Oncologist 2010; 15:523-530.
23. Cleveland RJ, Eng SM, Abrahamson PE, et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:1803-1811. (Pubitemid 47450510)
24. Skipworth RJ, Fearon KC. The scientific rationale for optimizing nutritional support in cancer. Eur J Gastroenterol Hepatol 2007; 19:371-377. (Pubitemid 46596689)
25. Kirkova J, Davis MP, Walsh D, et al. Cancer symptom assessment instruments: a systematic review. J Clin Oncol 2006; 24:1459-1473. (Pubitemid 46622014)
26. Corner J, Hopkinson J, Fitzsimmons D, et al. Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis. Thorax 2005; 60:314-319. (Pubitemid 40522368)
27. Khalid U, Spiro A, Baldwin C, et al. Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 2007; 15:39-46. (Pubitemid 46088312)
28. Donnelly S, Walsh D, Rybicki L. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care 1995; 11:27-32.
29. Sarhill N, Mahmoud F, Walsh D, et al. Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 2003; 11:652-659. (Pubitemid 37243596)
30. Walsh TD, Bowman KB, Jackson GP. Dietary intake of advanced cancer patients. Hum Nutr Appl Nutr 1983; 37:41-45. (Pubitemid 13123552)
31. Andrews IM, Waterfield K, Hildreth AJ, et al. Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome. Pall Med 2009; 23:680-688.
32. Baldwin C, Spiro A, McGough C, et al. The NUT study: the effect of dietetic and oral nutritional interventions on survival and quality of life in patients with weight loss undergoing palliative chemotherapy for gastrointestinal or lung malignancy, a randomised controlled trial. Proc Nutr Soc 2008; 67:E136.
33. Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003; 52:1479-1486. (Pubitemid 37176729)
34. Brown JK. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncol Nurs Forum 2002; 29:517-532.
35. Elia M, Van Bokhorst-de van der Schueren MA, Garvey J, et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 2006; 28:5-23.
36. Koretz RL, Avenell A, Lipman TO, et al. Does enteral. Am J Gastroenterol 2007; 102:412-429.
37. Halfdanarson TR, Thordardottir E, West CP, Jatoi A. Does dietary counseling improve quality of life in cancer patients? A systematic review and metaanalysis. J Support Oncol 2008; 6:234-237. (Pubitemid 351836612)
38. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365-376. (Pubitemid 23073154)
39. Mantovani G, Madeddu C. Cancer cachexia: medical management. Support Care Cancer 2010; 18:1-9. A review of the evidence for novel treatments used in the management of cachexia subdivided into those that are commonly used, drugs with a strong rationale that failed, emerging drugs with promising results and future trends.
40. Dodson S, Baracos VE, Jatoi A, et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 2010; [Epub ahead of print]
41. Baldwin C, Spiro A, Milligan PJ, et al. Is weight change an appropriate marker of nutritional intervention in patients with cancer. Proc Nutr Soc 2009; 68:E1.
42. Koretz RL. Should patients with cancer be offered nutritional support: does the benefit outweigh the burden. Eur J Gastroenterol Hepatol 2007; 19:379-382. (Pubitemid 46596690)
43. Yavuzsen T, Davis MP, Walsh D, et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol 2005; 23:8500-8511.
44. Persson CR, Glimelius B, Ronnelid J, Nygren P. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition 2005; 21:170-178. (Pubitemid 40255726)
45. Lundholm K, Daneryd P, Bosaeus I, et al. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 2004; 100:1967-1977. (Pubitemid 38529575)
46. McMillan DC, Wigmore SJ, Fearon KC, et al. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 1999; 79:495-500. (Pubitemid 29046225)